149 related articles for article (PubMed ID: 3086583)
1. Bone and mineral status of patients beginning total parenteral nutrition.
Epstein S; Traberg H; Levine G; McClintock R
JPEN J Parenter Enteral Nutr; 1986; 10(3):263-4. PubMed ID: 3086583
[TBL] [Abstract][Full Text] [Related]
2. Metabolic bone disease associated with total parenteral nutrition.
Klein GL; Coburn JW
Adv Nutr Res; 1984; 6():67-92. PubMed ID: 6439013
[TBL] [Abstract][Full Text] [Related]
3. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects.
Nielsen HK; Thomsen K; Eriksen EF; Charles P; Storm T; Mosekilde L
Bone Miner; 1988 Apr; 4(1):105-13. PubMed ID: 3263890
[TBL] [Abstract][Full Text] [Related]
4. Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.
Goodman WG; Misra S; Veldhuis JD; Portale AA; Wang HJ; Ament ME; Salusky IB
Am J Clin Nutr; 2000 Feb; 71(2):560-8. PubMed ID: 10648272
[TBL] [Abstract][Full Text] [Related]
5. Serum osteocalcin is increased in patients with osteomalacia: correlations with biochemical and histomorphometric findings.
Demiaux B; Arlot ME; Chapuy MC; Meunier PJ; Delmas PD
J Clin Endocrinol Metab; 1992 May; 74(5):1146-51. PubMed ID: 1569162
[TBL] [Abstract][Full Text] [Related]
6. Serum markers of bone formation in parenteral nutrition patients.
Lipkin EW; Ott SM; Klein GL; Deftos LJ
Calcif Tissue Int; 1990 Aug; 47(2):75-81. PubMed ID: 2117992
[TBL] [Abstract][Full Text] [Related]
7. Influence of PTH and 1,25(OH)2D on calcium homeostasis and bone mineral content after gastric surgery.
Nilas L; Christiansen C
Calcif Tissue Int; 1985 Sep; 37(5):461-6. PubMed ID: 3933787
[TBL] [Abstract][Full Text] [Related]
8. Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.
Ismail F; Epstein S; Pacifici R; Droke D; Thomas SB; Avioli LV
Calcif Tissue Int; 1986 Oct; 39(4):230-3. PubMed ID: 3098385
[TBL] [Abstract][Full Text] [Related]
9. [Effect of total parenteral nutrition on bone metabolism].
León-Sanz M; Gómez I; Marfagón N; Larrodera L; Hawkins F
Nutr Hosp; 1992; 7(4):270-4. PubMed ID: 1391109
[TBL] [Abstract][Full Text] [Related]
10. Deranged bone mineral metabolism in chronic alcoholism.
Feitelberg S; Epstein S; Ismail F; D'Amanda C
Metabolism; 1987 Apr; 36(4):322-6. PubMed ID: 3494181
[TBL] [Abstract][Full Text] [Related]
11. Bone composition and vitamin D after Pólya gastrectomy.
Tougaard L; Rickers H; Rödbro P; Thaysen EH; Christensen MS; Lund B; Sörensen OH
Acta Med Scand; 1977; 202(1-2):47-50. PubMed ID: 899882
[TBL] [Abstract][Full Text] [Related]
12. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
13. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
Offermann G; Schaefer K; Schulz A; Delling G
Klin Wochenschr; 1976 Jul; 54(13):625-32. PubMed ID: 940299
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
Malluche HH; Faugere MC; Fanti P; Price PA
Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of the decrease in metacarpal bone mineral content due to oophorectomy].
Ohta H; Nemoto K; Nozawa S; Iizuka R
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):333-40. PubMed ID: 2786542
[TBL] [Abstract][Full Text] [Related]
16. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up.
Coen G; Mazzaferro S; Bonucci E; Taggi F; Ballanti P; Bianchi AR; Donato G; Massimetti C; Smacchi A; Cinotti GA
Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905
[TBL] [Abstract][Full Text] [Related]
17. Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect.
Shike M; Shils ME; Heller A; Alcock N; Vigorita V; Brockman R; Holick MF; Lane J; Flombaum C
Am J Clin Nutr; 1986 Jul; 44(1):89-98. PubMed ID: 3088971
[TBL] [Abstract][Full Text] [Related]
18. Multifactorial low remodeling bone disease during cyclic total parenteral nutrition.
de Vernejoul MC; Messing B; Modrowski D; Bielakoff J; Buisine A; Miravet L
J Clin Endocrinol Metab; 1985 Jan; 60(1):109-13. PubMed ID: 3917265
[TBL] [Abstract][Full Text] [Related]
19. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
Klein GL; Horst RL; Norman AW; Ament ME; Slatopolsky E; Coburn JW
Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
[TBL] [Abstract][Full Text] [Related]
20. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
Orwoll ES; Meier DE
J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
